![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Amgen Astellas Biopharma and Astellas Introduce new treatment option for the high cholesterol patients
FIrst PCSK9 Inhibitor in Japan,Providing A new TREATMENT option for certain patients who have...
Boehringer Ingelheim and Eli Lilly company plans to conduct Jardiance® (empagliflozin) to be studied...
New studies will evaluate the effect of JARDIANCE for the treatment of chronic...
Baxter announced the launch of a ready-to-use VANCOMYCIN Injection in sodium chloride for US
Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World...
Top 5 Ways to Avoid Drug Errors
Every month millions of Americans pick up their prescription at the pharmacy, only to discover...
The Specialty Pharmacy: A One-to-One Personalized Approach
Maybe you’ve noticed: medications are getting more complicated, more personalized, and more expensive.
Look at some...
Diabetes Symptoms & Complications
Symptoms
People with type 1 or type 2 diabetes may have a range of symptoms. These...
Diabetes Risk Factors & Prevention
Risk Factors
Risk factors are characteristics that can predispose you to developing a condition or disease....
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT (Amphetamine Extended-Release Orally Disintegrating Tablet) for...
Neos Therapeutics, Inc, a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product...
FDA Approves Zepatier (elbasvir and grazoprevir) for Chronic Hepatitis C Genotypes 1 and 4
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without...
Teva’s Dedication and Commitment Recognized by Patients
Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients....